THE BONE GROWTH PRODUCTS MARKET SIZE WAS VALUED AT USD 1.1 BILLION IN 2021 AND IS EXPECTED TO REACH USD 1.4 BILLION BY 2027, GROWING AT A CAGR OF 3.60% DURING THE PERIOD 2022-2027.

The Bone Growth Products Market Size, Share, & Trends Analysis Report by

  • Product Type: Bone Growth Stimulator Device, Bone Morphogenic Protein, Platelet Rich Plasma
  • Application: Spinal Fusion Surgeries, Oral and Maxillofacial Surgeries, Delayed Union and Non-Union Bone Fracture, and Others
  • End-User: Hospitals and Clinic, Specialty Orthopaedic and Spine Center, and Ambulatory Surgery Centers
  • Geography: Europe, North America, APAC, Latin America, and the Middle East and Africa

Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast 2022–2027.

Licence Types What are these?
GET ACTIONABLE INSIGHTS ON HOW COVID-19 IS IMPACTING YOUR BUSINESS
Enquire Now Download Free Sample

Most Exhaustive Report

icon-pages

317 Pages

icon-table

142 Tables

icon-chart

141 Charts

icon-region

5 Regions

icon-country

18 Countries

icon-company

26 Companies

icon-market

4 Market Segment

BONE GROWTH PRODUCTS MARKET REPORT SCOPE

Report Attribute Details
MARKET SIZE USD 1.4 Billion (2027)
CAGR 3.60% (2022-2027)
BASE YEAR 2021
FORECAST PERIOD 2022–2027
MARKET SEGMENTS Product Type (Bone Growth Stimulator Device, Bone Morphogenic Protein, Platelet Rich Plasma), Application (Spinal Fusion Surgeries, Oral and Maxillofacial Surgeries, Delayed Union and Non-Union Bone Fracture, and Others), End-User (Hospitals and Clinic, Specialty Orthopaedic and Spine Center, and Ambulatory Surgery Centers)
GEOGRAPHICAL ANALYSIS Europe, North America, APAC, Latin America, and Middle East and Africa
COUNTRIES COVERED US, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, Brazil, Mexico, Argentina, Turkey, Saudi Arabia, South Africa

MARKET OVERVIEW

The global bone growth products market was valued at USD 1.1 billion and is projected to reach USD 1.4 billion in 2027, growing at a CAGR of 3.60% from 2022 to 2027. Bone growth products such as stimulator devices, bone morphogenetic proteins, and platelet-rich plasma help repair bone damage and speed up the bone healing process. Bone regeneration comprises a well-orchestrated series of biological events of bone induction and conduction, involving several cell types and intracellular and extracellular molecular-signaling pathways, with a definable temporal and spatial sequence, to optimize skeletal repair and restore skeletal functions. The global bone growth products are vast and offer significant opportunities for new vendors if they develop and commercialize breakthrough bone growth products. As a result, many local and emerging players are actively developing innovative bone stimulators for treating various bone disorders. However, as key players account for dominant shares and have superior product development and industrial expertise, technological advancements like self-powered implantable bone growth, non-invasive growth stimulator, and product launches are mainly driving the demand for the product.

KEY POINTS

  • APAC is likely to grow faster and record the highest absolute growth (33.44%) during the forecast period. In contrast, North America, which dominates the global bone growth products, will witness absolute growth (19.97%) during the forecast period.
  • Vendors are actively launching innovative bone growth products to expand their customer base and increase share in the highly competitive market. Vendors strategically focus on the development and commercial launch of bone growth products to treat a broad range of bone pathology.
  • The major advantage of the self-powered bone growth stimulator is that it provides an immediate solution; due to the increased benefits of the implantable bone growth stimulator device, the adoption of this type of device will be seen mainly among the developed countries. Slowly multiple researchers are evaluating the efficiency and effectiveness of the product for better adoption of the business presence.
  • The increasing number of cases of spinal fractures is expected to expand the business over the forecast period. The gradual shift and increasing demand for non-invasive surgery, the rapid introduction of biologics into spinal fusion, and the significant increase in cervical and lumbar disc replacements will further boost the bone growth products market during the forecast period.

SEGMENTATION ANALYSIS

  • In 2021, the bone growth stimulator devices segment accounted for 51.12% of the global bone growth products market share; the ultrasonic bone growth stimulator is premarket approved (PMA) by the U.S. Food and Drug Administration (FDA) as a Class III Device, thereby, various changes have been incorporated into the device and given additional approval. This device is now known as the Exogen device (i.e., 2000, 3000, 4000).
  • The spinal fusion surgeries segment dominates the global bone growth products market, accounting for a share of 58.24%, followed by oral & maxillofacial surgeries, delayed union & non-union bone fractures, and others with 18.90%, 9.78%, and 13.08%, respectively.
  • In developing countries like India, the importance of MI spine surgery is also growing. The exponential growth of spinal training facilities and efficiency in private and corporate hospitals in emerging markets also contributes to the growth of the hospitals' segment in the global bone growth products.

VENDOR ANALYSIS

  • Bioventus medical device company focused on developing and commercializing clinically differentiated, cost-effective, minimally invasive therapies that enhance the body's natural healing process. Its non-invasive medical devices and biological products play an essential role in supporting the body's natural healing mechanisms for treating or eliminating the pain caused by orthopedic diseases and problems, eventually aiding the product's growth.
  • Colfax’s DJO is one of the world's largest suppliers of high-quality orthopedic devices, and in the U.S., Colfax acquired DJO in the first quarter of 2019. The company's products are sold in portfolios of Aircast, Chattanooga, CMF, Compex, DJO Surgical, DonJoy and Dr. Comfort, Exo, MotionMD, and ProCare.
  • Medtronic develops, manufactures, and markets bone growth products and offers biologic solutions for the orthopedic and dental markets and products for the neurosurgery business. The company focuses on technological innovations and acquisitions to retain its market dominance and enhance its global bone growth products markets.

GEOGRAPHICAL ANALYSIS

  • North America accounted for a share of over 41% of the global bone growth products market in 2021, due to the presence of a large pool of patient population with various spinal disorders requiring spinal fusion surgeries, higher acceptance of advanced and innovative bone growth products, and high awareness regarding the benefits of non-invasive surgery procedures are collectively supporting the market growth of bone growth products in North America.
  • Europe accounted for a 27.45% share of the global bone growth products market in 2021. The major revenue contributors in Europe are Germany, the UK, France, Italy, and Spain. The growing technological advancements in design and material usage in bone growth products technology and new product approvals/ launches will also positively impact the growth during the forecast period.
  • APAC offers vendors lucrative opportunities to uptake a diverse range of bone growth stimulator devices. Furthermore, favorable government initiatives, improvement in healthcare infrastructure, and increased healthcare spending are also expected to drive the bone growth products market in the region during the forecast period.

The research report includes in-depth coverage of the industry analysis with revenue and forecast insights for the following segments:

Segmentation by Product Type

  • Bone Growth Stimulator Device
  • Bone Morphogenic Protein
  • Platelet Rich Plasma

Segmentation by Application

  • Spinal Fusion Surgeries
  • Oral and Maxillofacial Surgeries
  • Delayed Union and Non-Union Bone Fracture
  • Others

Segmentation by Application

  • Hospitals and Clinic
  • Specialty Orthopaedic and Spine Center
  • Ambulatory Surgery Centers

Segmentation by Geography

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • UK
  • APAC
    • China
    • Japan
    • India
    • Australia
    • South Korea
  • Latin America
    • Mexico
    • Brazil
    • Argentina
  • The Middle East and Africa
    • South Africa
    • Saudi Arabia
    • Turkey

Frequently Asked Questions

What is the size of the bone growth products and the growth rate during the forecast period?

The global bone growth products market was valued at USD 1,178.00 million in 2021 and is likely to reach USD 1,456.43million by 2027, growing at a CAGR of 3.60% during the forecast period.

Which region has the highest growth rate in the bone growth products market?

APAC region has the highest growth rate of 4.93% during the forecast period.

Who are the key players in the bone growth products industry?

Bioventus, DJO, Johnson & Johnson are some of the key players in the bone growth products market.

What are the factors driving the demand for the bone growth products market?

The presence of a large pool of patient population, an increase in government initiatives and funding on healthcare, and improvements in healthcare infrastructure are the main factors driving the market growth.

What are the trends in the bone growth products market?

Self-Powered Implantable Bone Growth Device Stimulates Fast Bone Healing, Increasing Usage of Bone Morphogenic Proteins as an Alternative to Autografts, Next Generation Mobile Bone Growth Stimulation Devices are the trends in the bone growth products market.

Download Free Sample

The bone-growing products market by revenue is expected to grow at a CAGR of over 3.60% during the period 2022–2027.

The following factors are likely to contribute to the growth of the market during the forecast period

  • Increasing Target Population Demanding for Bone Growth Products
  • Increase in Demand for Non-invasive and Safer Surgical Treatments
  • Increasing Strategic Acquisitions and New Bone Growth Product Launches

Base Year: 2021

Forecast Year: 2022-2027

The report considers the present scenario of bone growth products and their market dynamics for the period 2022−2027. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the market. It also profiles and analyses leading companies and several other prominent companies operating in the market.

PROMINENT VENDORS

  • Bioventus
    • Business Overview
    • Product Offerings
    • Key Strengths
    • Key Strategies
    • Key Opportunities
  • DJO
  • Johnson & Johnson
  • Medtronic
  • Orthofix Medical
  • Stryker
  • Zimmer Biomet

OTHER PROMINENT VENDORS

  • BTT Health
    • Business Overview
    • Product Offerings
  • Elizur
  • Fintek Bio-Electric
  • Isto Biologics
  • ITO
  • Kinex Medical Company
  • Ossatec Benelux
  • Osteotec
  • Paragon 28
  • Royal Biologics
  • Stimulate Health
  • Smith+Nephew
  • SpineVision
  • VQ OrthoCare

Market Segmentation by Product Type

  • Bone Growth Stimulator Device
  • Bone Morphogenic Protein
  • Platelet Rich Plasma

Market Segmentation by Application

  • Spinal Fusion Surgeries
  • Oral and Maxillofacial Surgeries
  • Delayed Union and Non-Union Bone Fracture
  • Others

Market Segmentation by Application

  • Hospitals and Clinic
  • Specialty Orthopaedic and Spine Center
  • Ambulatory Surgery Centers

Market Segmentation by Geography

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • UK
  • APAC
    • China
    • Japan
    • India
    • Australia
    • South Korea
  • Latin America
    • Mexico
    • Brazil
    • Argentina
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • Turkey

1 RESEARCH METHODOLOGY

2 RESEARCH OBJECTIVES

3 RESEARCH PROCESS

4 SCOPE & COVERAGE

4.1 MARKET DEFINITION

4.1.1 INCLUSIONS

4.1.2 EXCLUSIONS

4.1.3 MARKET ESTIMATION CAVEATS

4.2 BASE YEAR

4.3 SCOPE OF THE STUDY

4.3.1 MARKET SEGMENTATION BY PRODUCT

4.3.2 MARKET SEGMENTATION BY APPLICATION

4.3.3 MARKET SEGMENTATION BY END-USERS

4.3.4 MARKET SEGMENTATION BY GEOGRAPHY

5 REPORT ASSUMPTIONS & CAVEATS

5.1 KEY CAVEATS

5.2 CURRENCY CONVERSION

5.3 MARKET DERIVATION

6 MARKET AT A GLANCE

7 INTRODUCTION

7.1 OVERVIEW

8 MARKET OPPORTUNITIES & TRENDS

8.1 SELF-POWERED IMPLANTABLE BONE GROWTH DEVICES STIMULATE FAST BONE HEALING

8.2 USE OF BONE MORPHOGENIC PROTEINS AS ALTERNATIVE TO AUTOGRAFTS

8.3 NEXT GENERATION MOBILE BONE GROWTH STIMULATION DEVICES

9 MARKET GROWTH ENABLERS

9.1 GROWTH IN TARGET POPULATION

9.2 INCREASE IN DEMAND FOR NON-INVASIVE & SAFER SURGICAL TREATMENTS

9.3 RISE IN STRATEGIC ACQUISITIONS & NEW BONE GROWTH PRODUCT LAUNCHES

10 MARKET GROWTH RESTRAINTS

10.1 STRINGENT REGULATORY APPROVAL PROCESS FOR BONE GROWTH PRODUCTS

10.2 SIDE-EFFECTS ASSOCIATED WITH BMP-BASED ORTHOPEDIC TREATMENT

10.3 AVAILABILITY OF MULTIPLE ALTERNATIVES

11 MARKET LANDSCAPE

11.1 MARKET OVERVIEW

11.2 MARKET SIZE & FORECAST

11.2.1 GEOGRAPHY INSIGHTS

11.2.2 PRODUCT INSIGHTS

11.2.3 APPLICATION INSIGHTS

11.2.4 END-USER INSIGHTS

11.3 FIVE FORCES ANALYSIS

11.3.1 THREAT OF NEW ENTRANTS

11.3.2 BARGAINING POWER OF SUPPLIERS

11.3.3 BARGAINING POWER OF BUYERS

11.3.4 THREAT OF SUBSTITUTES

11.3.5 COMPETITIVE RIVALRY

12 PRODUCT ANALYSIS

12.1 MARKET SNAPSHOT & GROWTH ENGINE

12.2 MARKET OVERVIEW

12.3 BONE GROWTH STIMULATOR DEVICES

12.3.1 MARKET OVERVIEW

12.3.2 MARKET SIZE & FORECAST

12.3.3 BONE GROWTH STIMULATION DEVICES SEGMENTATION: BY GEOGRAPHY

12.4 BONE MORPHOGENETIC PROTEIN (BMP)

12.4.1 MARKET OVERVIEW

12.4.2 MARKET SIZE & FORECAST

12.4.3 BONE MORPHOGENETIC PROTEINS SEGMENTATION: BY GEOGRAPHY

12.5 PLATELET RICH PLASMA

12.5.1 MARKET OVERVIEW

12.5.2 MARKET SIZE & FORECAST

12.5.3 PLATELET RICH PLASMA: BY GEOGRAPHY

13 APPLICATION SEGMENTATION

13.1 MARKET SNAPSHOT & GROWTH ENGINE

13.2 MARKET OVERVIEW

13.3 SPINAL FUSION SURGERIES

13.3.1 MARKET OVERVIEW

13.3.2 MARKET SIZE & FORECAST

13.3.3 SPINAL FUSION SURGERIES: BY GEOGRAPHY

13.4 ORAL & MAXILLOFACIAL SURGERIES

13.4.1 MARKET OVERVIEW

13.4.2 MARKET SIZE & FORECAST

13.4.3 ORAL & MAXILLOFACIAL SURGERIES SEGMENTATION: BY GEOGRAPHY

13.5 DELAYED UNION & NON-UNION BONE FRACTURES

13.5.1 MARKET OVERVIEW

13.5.2 MARKET SIZE & FORECAST

13.5.3 DELAYED UNION & NON-UNION BONE FRACTURES SEGMENTATION: BY GEOGRAPHY

13.6 OTHERS

13.6.1 MARKET OVERVIEW

13.6.2 MARKET SIZE & FORECAST

13.6.3 OTHERS SEGMENTATION: BY GEOGRAPHY

14 END-USER ANALYSIS

14.1 MARKET SNAPSHOT & GROWTH ENGINE

14.2 MARKET OVERVIEW

14.3 HOSPITALS & CLINICS

14.3.1 MARKET OVERVIEW

14.3.2 MARKET SIZE & FORECAST

14.3.3 HOSPITALS & CLINICS SEGMENTATION: BY GEOGRAPHY

14.4 SPECIALTY ORTHOPEDIC & SPINE CENTERS

14.4.1 MARKET OVERVIEW

14.4.2 MARKET SIZE & FORECAST

14.4.3 SPECIALTY ORTHOPEDIC & SPINE CENTERS SEGMENTATION: BY GEOGRAPHY

14.5 AMBULATORY SURGICAL CENTERS (ASC)

14.5.1 MARKET OVERVIEW

14.5.2 MARKET SIZE & FORECAST

14.5.3 ASCS SEGMENTATION: BY GEOGRAPHY

15 GEOGRAPHIC INSIGHTS

15.1 MARKET SNAPSHOT & GROWTH ENGINE

15.2 GEOGRAPHIC OVERVIEW

16 NORTH AMERICA

16.1 MARKET OVERVIEW

16.2 MARKET SIZE & FORECAST

16.2.1 NORTH AMERICA PRODUCT TYPE SEGMENTATION

16.2.2 NORTH AMERICA APPLICATION SEGMENTATION

16.2.3 NORTH AMERICA END-USER SEGMENTATION

16.3 KEY COUNTRIES

16.3.1 US: MARKET SIZE & FORECAST

16.3.2 CANADA: MARKET SIZE & FORECAST

17 EUROPE

17.1 MARKET OVERVIEW

17.2 MARKET SIZE & FORECAST

17.2.1 EUROPE PRODUCT TYPE SEGMENTATION

17.2.2 EUROPE APPLICATION SEGMENTATION

17.2.3 EUROPE END-USER SEGMENTATION

17.3 KEY COUNTRIES

17.3.1 GERMANY: MARKET SIZE & FORECAST

17.3.2 FRANCE: MARKET SIZE & FORECAST

17.3.3 UK: MARKET SIZE & FORECAST

17.3.4 ITALY: MARKET SIZE & FORECAST

17.3.5 SPAIN: MARKET SIZE & FORECAST

18 APAC

18.1 MARKET OVERVIEW

18.2 MARKET SIZE & FORECAST

18.2.1 APAC PRODUCT TYPE SEGMENTATION

18.2.2 APAC APPLICATION SEGMENTATION

18.2.3 APAC END-USER SEGMENTATION

18.3 KEY COUNTRIES

18.3.1 CHINA: MARKET SIZE & FORECAST

18.3.2 JAPAN: MARKET SIZE & FORECAST

18.3.3 INDIA: MARKET SIZE & FORECAST

18.3.4 AUSTRALIA: MARKET SIZE & FORECAST

18.3.5 SOUTH KOREA: MARKET SIZE & FORECAST

19 LATIN AMERICA

19.1 MARKET OVERVIEW

19.2 MARKET SIZE & FORECAST

19.2.1 LATIN AMERICA PRODUCT SEGMENTATION

19.2.2 LATIN AMERICA APPLICATION SEGMENTATION

19.2.3 LATIN AMERICA END-USER SEGMENTATION

19.3 KEY COUNTRIES

19.3.1 BRAZIL: MARKET SIZE & FORECAST

19.3.2 MEXICO: MARKET SIZE & FORECAST

19.3.3 ARGENTINA: MARKET SIZE & FORECAST

20 MIDDLE EAST & AFRICA

20.1 MARKET OVERVIEW

20.2 MARKET SIZE & FORECAST

20.2.1 MIDDLE EAST & AFRICA PRODUCT TYPE SEGMENTATION

20.2.2 MIDDLE EAST & AFRICA APPLICATION SEGMENTATION

20.2.3 MIDDLE EAST & AFRICA END-USER SEGMENTATION

20.3 KEY COUNTRIES

20.3.1 TURKEY: MARKET SIZE & FORECAST

20.3.2 SAUDI ARABIA: MARKET SIZE & FORECAST

20.3.3 SOUTH AFRICA: MARKET SIZE & FORECAST

21 COMPETITIVE LANDSCAPE

21.1 COMPETITION OVERVIEW

21.2 MARKET SHARE ANALYSIS

21.2.1 BIOVENTUS

21.2.2 DJO

21.2.3 JOHNSON & JOHNSON

21.2.4 MEDTRONIC

21.2.5 ORTHOFIX

21.2.6 STRYKER

21.2.7 ZIMMER BIOMET

22 KEY COMPANY PROFILES

22.1 BIOVENTUS

22.1.1 BUSINESS OVERVIEW

22.1.2 PRODUCT OFFERINGS

22.1.3 KEY STRATEGIES

22.1.4 KEY STRENGTHS

22.1.5 KEY OPPORTUNITIES

22.2 DJO

22.2.1 BUSINESS OVERVIEW

22.2.2 PRODUCT OFFERINGS

22.2.3 KEY STRATEGIES

22.2.4 KEY STRENGTHS

22.2.5 KEY OPPORTUNITIES

22.3 JOHNSON & JOHNSON

22.3.1 BUSINESS OVERVIEW

22.3.2 PRODUCT OFFERINGS

22.3.3 KEY STRATEGIES

22.3.4 KEY STRENGTHS

22.3.5 KEY OPPORTUNITIES

22.4 MEDTRONIC

22.4.1 BUSINESS OVERVIEW

22.4.2 PRODUCT OFFERINGS

22.4.3 KEY STRATEGIES

22.4.4 KEY STRENGTHS

22.4.5 KEY OPPORTUNITIES

22.5 ORTHOFIX

22.5.1 BUSINESS OVERVIEW

22.5.2 PRODUCT OFFERINGS

22.5.3 KEY STRATEGIES

22.5.4 KEY STRENGTHS

22.5.5 KEY OPPORTUNITIES

22.6 STRYKER

22.6.1 BUSINESS OVERVIEW

22.6.2 PRODUCT OFFERINGS

22.6.3 KEY STRATEGIES

22.6.4 KEY STRENGTHS

22.6.5 KEY OPPORTUNITIES

22.7 ZIMMER BIOMET

22.7.1 BUSINESS OVERVIEW

22.7.2 PRODUCT OFFERINGS

22.7.3 KEY STRATEGIES

22.7.4 KEY STRENGTHS

22.7.5 KEY OPPORTUNITIES

23 OTHER PROMINENT VENDORS

23.1 ALTIS BIOLOGICS

23.1.1 BUSINESS OVERVIEW

23.1.2 PRODUCT OFFERINGS

23.2 BIO DYNAMIC TECHNOLOGIES

23.2.1 BUSINESS OVERVIEW

23.2.2 PRODUCT OFFERINGS

23.3 BTT HEALTH

23.3.1 BUSINESS OVERVIEW

23.3.2 PRODUCT OFFERINGS

23.4 CELLUMED

23.4.1 BUSINESS OVERVIEW

23.4.2 PRODUCT OFFERINGS

23.5 EASTERN DME

23.5.1 BUSINESS OVERVIEW

23.5.2 PRODUCT OFFERINGS

23.6 ELIZUR

23.6.1 BUSINESS OVERVIEW

23.6.2 PRODUCT OFFERINGS

23.7 EMCYTE

23.7.1 BUSINESS OVERVIEW

23.7.2 PRODUCT OFFERINGS

23.8 FINTEK BIO-ELECTRIC

23.8.1 BUSINESS OVERVIEW

23.8.2 PRODUCT OFFERINGS

23.9 IGEA

23.9.1 BUSINESS OVERVIEW

23.9.2 PRODUCT OFFERINGS

23.10 ITO

23.10.1 BUSINESS OVERVIEW

23.10.2 PRODUCT OFFERINGS

23.11 KINEX MEDICAL

23.11.1 BUSINESS OVERVIEW

23.11.2 PRODUCT OFFERINGS

23.12 OSSATEC BENELUX

23.12.1 BUSINESS OVERVIEW

23.12.2 PRODUCT OFFERINGS

23.13 PAIN REHAB PRODUCTS

23.13.1 BUSINESS OVERVIEW

23.13.2 PRODUCT OFFERINGS

23.14 ROYAL BIOLOGICS

23.14.1 BUSINESS OVERVIEW

23.14.2 PRODUCT OFFERINGS

23.15 SHENANDOAH BIOTECHNOLOGY

23.15.1 BUSINESS OVERVIEW

23.15.2 PRODUCT OFFERINGS

23.16 SMITH+NEPHEW

23.16.1 BUSINESS OVERVIEW

23.16.2 PRODUCT OFFERINGS

23.17 SPECIALIZED ORTHOPEDIC SOLUTIONS

23.17.1 BUSINESS OVERVIEW

23.17.2 PRODUCT OFFERINGS

23.18 STIMULATE HEALTH

23.18.1 BUSINESS OVERVIEW

23.18.2 PRODUCT OFFERINGS

23.19 TERUMO

23.19.1 BUSINESS OVERVIEW

23.19.2 PRODUCT OFFERINGS

24 REPORT SUMMARY

24.1 KEY TAKEAWAYS

24.2 STRATEGIC RECOMMENDATIONS

25 QUANTITATIVE SUMMARY

25.1 MARKET BY PRODUCT TYPE

25.1.1 NORTH AMERICA: PRODUCT TYPE SEGMENTATION

25.1.2 EUROPE: PRODUCT TYPE SEGMENTATION

25.1.3 APAC: PRODUCT TYPE SEGMENTATION

25.1.4 LATIN AMERICA: PRODUCT TYPE SEGMENTATION

25.1.5 MIDDLE EAST & AFRICA: PRODUCT TYPE SEGMENTATION

25.2 MARKET BY APPLICATION

25.2.1 NORTH AMERICA: APPLICATION SEGMENTATION

25.2.2 EUROPE: APPLICATION SEGMENTATION

25.2.3 APAC: APPLICATION SEGMENTATION

25.2.4 LATIN AMERICA: APPLICATION SEGMENTATION

25.2.5 MIDDLE EAST & AFRICA: APPLICATION SEGMENTATION

25.3 MARKET BY END-USER

25.3.1 NORTH AMERICA: END-USER SEGMENTATION

25.3.2 EUROPE: END-USER SEGMENTATION

25.3.3 APAC: END-USER SEGMENTATION

25.3.4 LATIN AMERICA: END-USER SEGMENTATION

25.3.5 MIDDLE EAST & AFRICA: END-USER SEGMENTATION

25.4 MARKET BY GEOGRAPHY

25.4.1 BONE GROWTH STIMULATOR DEVICES SEGMENTATION: BY GEOGRAPHY

25.4.2 BONE MORPHOGENETIC PROTEIN SEGMENTATION: BY GEOGRAPHY

25.4.3 PLATELET RICH PLASMA SEGMENTATION: BY GEOGRAPHY

25.4.4 SPINAL FUSION SURGERIES SEGMENTATION: BY GEOGRAPHY

25.4.5 ORAL & MAXILLOFACIAL SURGERIES SEGMENTATION: BY GEOGRAPHY

25.4.6 DELAYED UNION & NON-UNION BONE FRACTURES: BY GEOGRAPHY

25.4.7 OTHERS SEGMENTATION: BY GEOGRAPHY

25.4.8 HOSPITALS & CLINICS SEGMENTATION: BY GEOGRAPHY

25.4.9 SPECIALTY ORTHOPEDIC & SPINE CENTER SEGMENTATION: BY GEOGRAPHY

25.4.10 ASCS SEGMENTATION: BY GEOGRAPHY

26 APPENDIX

26.1 ABBREVIATIONS

LIST OF EXHIBITS

EXHIBIT 1 SEGMENTATION OF GLOBAL BONE GROWTH PRODUCTS MARKET

EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2021

EXHIBIT 3 IMPACT OF SELF-POWERED IMPLANTABLE BONE GROWTH DEVICES STIMULATE FAST BONE HEALING

EXHIBIT 4 IMPACT OF USE OF BONE MORPHOGENIC PROTEINS AS ALTERNATIVE TO AUTOGRAFTS

EXHIBIT 5 DISADVANTAGES OF AUTOGENOUS BONE GRAFTS

EXHIBIT 6 IMPACT OF NEXT GENERATION MOBILE BONE GROWTH STIMULATION DEVICES

EXHIBIT 7 IMPACT OF GROWTH IN TARGET POPULATION

EXHIBIT 8 IMPACT OF INCREASE IN DEMAND FOR NON-INVASIVE & SAFER SURGICAL TREATMENTS

EXHIBIT 9 IMPACT OF RISE IN STRATEGIC ACQUISITIONS & NEW BONE GROWTH PRODUCT LAUNCHES

EXHIBIT 10 IMPACT OF STRINGENT REGULATORY APPROVAL PROCESS FOR BONE GROWTH PRODUCTS

EXHIBIT 11 IMPACT OF SIDE-EFFECTS ASSOCIATED WITH BMP-BASED ORTHOPEDIC TREATMENT

EXHIBIT 12 IMPACT OF AVAILABILITY OF MULTIPLE ALTERNATIVES

EXHIBIT 13 GLOBAL BONE GROWTH PRODUCTS MARKET 2021–2027 ($ MILLION)

EXHIBIT 14 GLOBAL BONE GROWTH PRODUCTS MARKET BY GEOGRAPHY 2021 & 2027 (%)

EXHIBIT 15 GLOBAL BONE GROWTH PRODUCTS MARKET BY PRODUCT TYPE 2021 & 2027 (%)

EXHIBIT 16 GLOBAL BONE GROWTH PRODUCTS MARKET BY APPLICATION 2021 & 2027 (%)

EXHIBIT 17 GLOBAL BONE GROWTH PRODUCTS MARKET BY END-USER 2021 & 2027 (%)

EXHIBIT 18 FIVE FORCES ANALYSIS 2021

EXHIBIT 19 INCREMENTAL GROWTH BY PRODUCT TYPE 2021 & 2027

EXHIBIT 20 GLOBAL BONE GROWTH PRODUCTS MARKET BY PRODUCT

EXHIBIT 21 GLOBAL BONE GROWTH PRODUCTS MARKET BY PRODUCT TYPE: INCREMENTAL GROWTH ($ MILLION)

EXHIBIT 22 GLOBAL BONE GROWTH PRODUCTS MARKET BY PRODUCT TYPE: ABSOLUTE GROWTH (%)

EXHIBIT 23 GLOBAL BONE GROWTH PRODUCTS MARKET BY BONE GROWTH STIMULATORS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 24 GLOBAL BONE GROWTH STIMULATOR DEVICES MARKET 2021–2027 ($ MILLION)

EXHIBIT 25 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 26 HISTORY OF BONE MORPHOGENETIC PROTEIN (BMP) EVOLUTION

EXHIBIT 27 BMP'S ROLE IN BONE FORMATION, GROWTH, & DIFFERENTIATION

EXHIBIT 28 GLOBAL BONE MORPHOGENETIC PROTEIN MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 29 GLOBAL BONE MORPHOGENETIC PROTEINS MARKET 2021–2027 ($ MILLION)

EXHIBIT 30 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 31 GLOBAL PLATELET RICH PLASMA MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 32 GLOBAL PLATELET RICH PLASMA MARKET 2021–2027 ($ MILLION)

EXHIBIT 33 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 34 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027

EXHIBIT 35 GLOBAL BONE GROWTH PRODUCTS MARKET BY APPLICATION

EXHIBIT 36 GLOBAL BONE GROWTH PRODUCTS MARKET BY APPLICATION: INCREMENTAL GROWTH ($ MILLION)

EXHIBIT 37 GLOBAL BONE GROWTH PRODUCTS MARKET BY APPLICATION: ABSOLUTE GROWTH (%)

EXHIBIT 38 GLOBAL SPINAL FUSION SURGERIES MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 39 GLOBAL SPINAL FUSION SURGERIES MARKET 2021–2027 ($ MILLION)

EXHIBIT 40 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 41 GLOBAL ORAL & MAXILLOFACIAL SURGERIES MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 42 GLOBAL ORAL & MAXILLOFACIAL SURGERIES MARKET 2021–2027 ($ MILLION)

EXHIBIT 43 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 44 GLOBAL DELAYED UNION & NON-UNION BONE FRACTURES MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 45 GLOBAL DELAYED UNION & NON-UNION BONE FRACTURES MARKET 2021–2027 ($ MILLION)

EXHIBIT 46 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 47 PREVALENCE OF STRESS FRACTURES IN VARIOUS PLACES

EXHIBIT 48 GLOBAL BONE GROWTH PRODUCTS MARKET BY OTHERS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 49 GLOBAL OTHER BONE GROWTH PRODUCTS MARKET 2021–2027 ($ MILLION)

EXHIBIT 50 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 51 INCREMENTAL GROWTH BY END-USER 2021 & 2027

EXHIBIT 52 GLOBAL BONE GROWTH PRODUCTS MARKET BY END-USER

EXHIBIT 53 GLOBAL BONE GROWTH PRODUCTS MARKET BY END-USER: INCREMENTAL GROWTH

EXHIBIT 54 GLOBAL BONE GROWTH PRODUCTS MARKET BY END-USER: ABSOLUTE GROWTH

EXHIBIT 55 GLOBAL HOSPITALS & CLINICS BONE GROWTH PRODUCTS MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 56 GLOBAL HOSPITALS & CLINICS BONE GROWTH PRODUCTS MARKET 2021–2027 ($ MILLION)

EXHIBIT 57 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 58 GLOBAL SPECIALTY ORTHOPEDIC & SPINE CENTER BONE GROWTH PRODUCTS MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 59 GLOBAL SPECIALTY ORTHOPEDIC & SPINE CENTER BONE GROWTH PRODUCTS MARKET 2021–2027 ($ MILLION)

EXHIBIT 60 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 61 GLOBAL BONE GROWTH PRODUCTS MARKET BY ASCS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 62 GLOBAL ASCS BONE GROWTH PRODUCTS MARKET 2021–2027 ($ MILLION)

EXHIBIT 63 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 64 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027

EXHIBIT 65 GLOBAL BONE GROWTH PRODUCTS MARKET BY GEOGRAPHY

EXHIBIT 66 GLOBAL BONE GROWTH PRODUCTS MARKET BY GEOGRAPHY: INCREMENTAL GROWTH

EXHIBIT 67 GLOBAL BONE GROWTH PRODUCTS MARKET BY GEOGRAPHY: ABSOLUTE GROWTH

EXHIBIT 68 GLOBAL BONE GROWTH PRODUCTS MARKET: COUNTRY REVENUE 2021 (MILLIONS)

EXHIBIT 69 NORTH AMERICA BONE GROWTH PRODUCTS MARKET: KEY COUNTRIES

EXHIBIT 70 NORTH AMERICA BONE GROWTH PRODUCTS MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 71 NORTH AMERICA BONE GROWTH PRODUCTS MARKET 2021–2027 ($ MILLION)

EXHIBIT 72 INCREMENTAL GROWTH BY PRODUCT 2021 & 2027

EXHIBIT 73 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027

EXHIBIT 74 INCREMENTAL GROWTH BY END-USER 2021 & 2027

EXHIBIT 75 INCREMENTAL GROWTH IN NORTH AMERICA 2021 & 2027

EXHIBIT 76 BONE GROWTH PRODUCTS MARKET IN US 2021–2027 ($ MILLION)

EXHIBIT 77 BONE GROWTH PRODUCTS MARKET IN CANADA 2021–2027 ($ MILLION)

EXHIBIT 78 BONE GROWTH PRODUCTS MARKET IN EUROPE: KEY COUNTRIES ($ MILLION)

EXHIBIT 79 EUROPE BONE GROWTH PRODUCTS MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 80 EUROPE BONE GROWTH PRODUCTS MARKET 2021–2027 ($ MILLION)

EXHIBIT 81 INCREMENTAL GROWTH BY PRODUCT TYPE 2021 & 2027

EXHIBIT 82 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027

EXHIBIT 83 INCREMENTAL GROWTH BY END-USER 2021 & 2027

EXHIBIT 84 INCREMENTAL GROWTH IN EUROPE 2021 & 2027

EXHIBIT 85 BONE GROWTH PRODUCTS MARKET IN GERMANY 2021–2027 ($ MILLION)

EXHIBIT 86 BONE GROWTH PRODUCTS MARKET IN FRANCE 2021–2027 ($ MILLION)

EXHIBIT 87 BONE GROWTH PRODUCTS MARKET IN UK 2021–2027 ($ MILLION)

EXHIBIT 88 BONE GROWTH PRODUCTS MARKET IN ITALY 2021–2027 ($ MILLION)

EXHIBIT 89 BONE GROWTH PRODUCTS MARKET IN SPAIN 2021–2027 ($ MILLION)

EXHIBIT 90 BONE GROWTH PRODUCTS MARKET IN APAC: KEY COUNTRIES

EXHIBIT 91 APAC BONE GROWTH PRODUCTS MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 92 APAC BONE GROWTH PRODUCTS MARKET 2021–2027 ($ MILLION)

EXHIBIT 93 INCREMENTAL GROWTH BY PRODUCT TYPE 2021 & 2027

EXHIBIT 94 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027

EXHIBIT 95 INCREMENTAL GROWTH BY END-USER 2021 & 2027

EXHIBIT 96 INCREMENTAL GROWTH IN APAC 2021 & 2027

EXHIBIT 97 BONE GROWTH PRODUCTS MARKET IN CHINA 2021–2027 ($ MILLION)

EXHIBIT 98 BONE GROWTH PRODUCTS MARKET IN JAPAN 2021–2027 ($ MILLION)

EXHIBIT 99 BONE GROWTH PRODUCTS MARKET IN INDIA 2021–2027 ($ MILLION)

EXHIBIT 100 BONE GROWTH PRODUCTS MARKET IN AUSTRALIA 2021–2027 ($ MILLION)

EXHIBIT 101 BONE GROWTH PRODUCTS MARKET IN SOUTH KOREA 2021–2027 ($ MILLION)

EXHIBIT 102 LATIN AMERICA BONE GROWTH PRODUCTS MARKET: KEY COUNTRIES

EXHIBIT 103 LATIN AMERICA BONE GROWTH PRODUCTS MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 104 BONE GROWTH PRODUCTS MARKET IN LATIN AMERICA 2021–2027 ($ MILLION)

EXHIBIT 105 INCREMENTAL GROWTH BY PRODUCT TYPE 2021 & 2027

EXHIBIT 106 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027

EXHIBIT 107 INCREMENTAL GROWTH BY END-USER 2021 & 2027

EXHIBIT 108 INCREMENTAL GROWTH IN LATIN AMERICA 2021 & 2027

EXHIBIT 109 BONE GROWTH PRODUCTS MARKET IN BRAZIL 2021–2027 ($ MILLION)

EXHIBIT 110 BONE GROWTH PRODUCTS MARKET IN MEXICO 2021–2027 ($ MILLION)

EXHIBIT 111 BONE GROWTH PRODUCTS MARKET IN ARGENTINA 2021–2027 ($ MILLION)

EXHIBIT 112 BONE GROWTH PRODUCTS IN MIDDLE EAST & AFRICA: KEY COUNTRIES

EXHIBIT 113 MIDDLE EAST & AFRICA BONE GROWTH PRODUCTS MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 114 MIDDLE EAST & AFRICA BONE GROWTH PRODUCTS MARKET 2021–2027 ($ MILLION)

EXHIBIT 115 INCREMENTAL GROWTH BY PRODUCT TYPE 2021 & 2027

EXHIBIT 116 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027

EXHIBIT 117 INCREMENTAL GROWTH BY END-USER 2021 & 2027

EXHIBIT 118 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2021 & 2027

EXHIBIT 119 BONE GROWTH PRODUCTS MARKET IN TURKEY 2021–2027 ($ MILLION)

EXHIBIT 120 BONE GROWTH PRODUCTS MARKET IN SAUDI ARABIA 2021–2027 ($ MILLION)

EXHIBIT 121 BONE GROWTH PRODUCTS MARKET IN SOUTH AFRICA 2021–2027 ($ MILLION)

EXHIBIT 122 PURE & DIVERSIFIED VENDORS IN GLOBAL BONE GROWTH PRODUCTS MARKET

EXHIBIT 123 MAJOR VENDORS IN GLOBAL BONE GROWTH PRODUCTS MARKET: STRENGTH ANALYSIS

EXHIBIT 124 KEY PLAYERS IN BONE GROWTH PRODUCTS MARKET

EXHIBIT 125 BIOVENTUS: TOTAL REVENUE 2018–2020 ($ MILLION)

EXHIBIT 126 BIOVENTUS: R&D EXPENDITURE 2018-2020 ($ MILLION)

EXHIBIT 127 JOHNSON & JOHNSON: TOTAL REVENUE 2018–2020 ($ MILLION)

EXHIBIT 128 JOHNSON & JOHNSON: R&D EXPENDITURE 2018–2020 ($ MILLION)

EXHIBIT 129 MEDTRONIC: TOTAL REVENUE 2019–2021 ($ MILLION)

EXHIBIT 130 MEDTRONIC: R&D EXPENDITURE 2019-2021 ($ MILLION)

EXHIBIT 131 MEDTRONIC: REVENUE BY BUSINESS SEGMENT 2020-2021 ($ MILLION)

EXHIBIT 132 MEDTRONIC: REVENUE BY GEOGRAPHY 2021 ($ MILLION)

EXHIBIT 133 ORTHOFIX: TOTAL REVENUE 2018–2020 ($ MILLION)

EXHIBIT 134 ORTHOFIX: R&D EXPENDITURE 2018–2020 ($ MILLION)

EXHIBIT 135 ORTHOFIX: REVENUE BY BUSINESS SEGMENT 2018–2020 ($ MILLION)

EXHIBIT 136 STRYKER: TOTAL REVENUE 2018–2020 ($ MILLION)

EXHIBIT 137 STRYKER: REVENUE BY BUSINESS SEGMENT 2020 ($ MILLION)

EXHIBIT 138 STRYKER: REVENUE BY GEOGRAPHY 2020 ($ MILLION)

EXHIBIT 139 ZIMMER BIOMET: TOTAL REVENUE 2018–2020 ($ MILLION)

EXHIBIT 140 ZIMMER BIOMET: REVENUE BY GEOGRAPHY 2019–2020 ($ MILLION)

EXHIBIT 141 ZIMMER BIOMET: REVENUE BY BUSINESS SEGMENT 2019–2020 ($ MILLION)

LIST OF TABLES

TABLE 1 KEY CAVEATS

TABLE 2 CURRENCY CONVERSION 2015−2021

TABLE 3 BIOLOGICAL ACTIONS OF BMP

TABLE 4 GLOBAL NUMBER OF INCIDENT & PREVALENT CASES OF FRACTURES BY ANATOMICAL SITE IN 2019

TABLE 5 MERGERS/ACQUISITIONS IN ORTHOPEDICS & BONE BIOLOGICS MARKET

TABLE 6 SIDE EFFECTS ASSOCIATED WITH USE OF BMP

TABLE 7 FDA APPROVED ELECTRICAL BONE GROWTH STIMULATION DEVICES

TABLE 8 BONE GROWTH PRODUCTS MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)

TABLE 9 BONE GROWTH PRODUCTS MARKET BY GEOGRAPHY 2021–2027 (%)

TABLE 10 VARIOUS CARRIER MATERIAL AVAILABLE FOR BMP

TABLE 11 GLOBAL BONE MORPHOGENETIC PROTEIN MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)

TABLE 12 GLOBAL BONE MORPHOGENETIC PROTEIN MARKET BY GEOGRAPHY 2021–2027 (%)

TABLE 13 GLOBAL PLATELET RICH PLASMA MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)

TABLE 14 GLOBAL PLATELET RICH PLASMA MARKET BY GEOGRAPHY 2021–2027 (%)

TABLE 15 GLOBAL SPINAL FUSION SURGERIES MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)

TABLE 16 GLOBAL SPINAL FUSION SURGERIES MARKET BY GEOGRAPHY 2021–2027 (%)

TABLE 17 GLOBAL ORAL MAXILLOFACIAL SURGERIES MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)

TABLE 18 GLOBAL ORAL MAXILLOFACIAL SURGERIES MARKET BY GEOGRAPHY 2021–2027 (%)

TABLE 19 DELAYED UNION & NON-UNION BONE FRACTURES MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)

TABLE 20 GLOBAL DELAYED UNION & NON-UNION BONE FRACTURES MARKET BY GEOGRAPHY 2021–2027 (%)

TABLE 21 PREVALENCE OF STRESS FRACTURE & INJURY

TABLE 22 GLOBAL OTHER BONE GROWTH PRODUCTS MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)

TABLE 23 GLOBAL OTHER BONE GROWTH PRODUCTS MARKET BY GEOGRAPHY 2021–2027 (%)

TABLE 24 GLOBAL HOSPITALS & CLINICS BONE GROWTH PRODUCTS MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)

TABLE 25 GLOBAL HOSPITALS & CLINICS BONE GROWTH PRODUCTS MARKET BY GEOGRAPHY 2021–2027 (%)

TABLE 26 SPECIALTY ORTHOPEDIC & SPINE CENTERS BONE GROWTH PRODUCTS MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)

TABLE 27 SPECIALTY ORTHOPEDIC & SPINE CENTERS BONE GROWTH PRODUCTS MARKET BY GEOGRAPHY 2021–2027 (%)

TABLE 28 ASCS BONE GROWTH PRODUCTS MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)

TABLE 29 ASCS BONE GROWTH PRODUCTS MARKET BY GEOGRAPHY 2021–2027 (%)

TABLE 30 NORTH AMERICA BONE GROWTH PRODUCTS MARKET BY PRODUCT TYPE 2021–2027 ($ MILLION)

TABLE 31 NORTH AMERICA BONE GROWTH PRODUCTS MARKET BY PRODUCT TYPE 2021–2027 (%)

TABLE 32 NORTH AMERICA BONE GROWTH PRODUCTS MARKET BY APPLICATION 2021–2027 ($ MILLION)

TABLE 33 NORTH AMERICA BONE GROWTH PRODUCTS MARKET BY APPLICATION 2021–2027 (%)

TABLE 34 NORTH AMERICA BONE GROWTH PRODUCTS MARKET BY END-USER 2021–2027 ($ MILLION)

TABLE 35 NORTH AMERICA BONE GROWTH PRODUCTS MARKET BY END-USER 2021–2027 (%)

TABLE 36 EUROPE BONE GROWTH PRODUCTS MARKET BY PRODUCT TYPE 2021–2027 ($ MILLION)

TABLE 37 EUROPE BONE GROWTH PRODUCTS MARKET BY PRODUCT TYPE 2021–2027 (%)

TABLE 38 EUROPE BONE GROWTH PRODUCTS MARKET BY APPLICATION 2021–2027 ($ MILLION)

TABLE 39 EUROPE BONE GROWTH PRODUCTS MARKET BY APPLICATION 2021–2027 (%)

TABLE 40 EUROPE BONE GROWTH PRODUCTS MARKET BY END-USER 2021–2027 ($ MILLION)

TABLE 41 EUROPE BONE GROWTH PRODUCTS MARKET BY END-USER 2021–2027 (%)

TABLE 42 APAC BONE GROWTH PRODUCTS MARKET BY PRODUCT TYPE 2021–2027 ($ MILLION)

TABLE 43 APAC BONE GROWTH PRODUCTS MARKET BY PRODUCT TYPE 2021–2027 (%)

TABLE 44 APAC BONE GROWTH PRODUCTS MARKET BY APPLICATION 2021–2027 ($ MILLION)

TABLE 45 APAC BONE GROWTH PRODUCTS MARKET BY APPLICATION 2021–2027 (%)

TABLE 46 APAC BONE GROWTH PRODUCTS MARKET BY END-USER 2021–2027 ($ MILLION)

TABLE 47 APAC BONE GROWTH PRODUCTS MARKET BY END-USER 2021–2027 (%)

TABLE 48 LATIN AMERICA BONE GROWTH PRODUCTS MARKET BY PRODUCT TYPE 2021–2027 ($ MILLION)

TABLE 49 LATIN AMERICA BONE GROWTH PRODUCTS MARKET BY PRODUCT TYPE 2021–2027 (%)

TABLE 50 LATIN AMERICA BONE GROWTH PRODUCTS MARKET BY APPLICATION 2021–2027 ($ MILLION)

TABLE 51 LATIN AMERICA BONE GROWTH PRODUCTS MARKET BY APPLICATION 2021–2027 (%)

TABLE 52 LATIN AMERICA BONE GROWTH PRODUCTS MARKET BY END-USER 2021–2027 ($ MILLION)

TABLE 53 LATIN AMERICA BONE GROWTH PRODUCTS MARKET BY END-USER 2021–2027 (%)

TABLE 54 MIDDLE EAST & AFRICA BONE GROWTH PRODUCTS MARKET BY PRODUCT TYPE 2021–2027 ($ MILLION)

TABLE 55 MIDDLE EAST & AFRICA BONE GROWTH PRODUCTS MARKET BY PRODUCT TYPE 2021–2027 (%)

TABLE 56 MIDDLE EAST & AFRICA BONE GROWTH PRODUCTS MARKET BY APPLICATION 2021–2027 ($ MILLION)

TABLE 57 MIDDLE EAST & AFRICA BONE GROWTH PRODUCTS MARKET BY APPLICATION 2021–2027 (%)

TABLE 58 MIDDLE EAST & AFRICA BONE GROWTH PRODUCTS MARKET BY END-USER 2021–2027 ($ MILLION)

TABLE 59 MIDDLE EAST & AFRICA BONE GROWTH PRODUCTS MARKET BY END-USER 2021–2027 (%)

TABLE 60 BIOVENTUS: MAJOR PRODUCT OFFERINGS

TABLE 61 DJO: MAJOR PRODUCT OFFERINGS

TABLE 62 JOHNSON & JOHNSON: MAJOR PRODUCT OFFERINGS

TABLE 63 MEDTRONIC: MAJOR PRODUCT OFFERINGS

TABLE 64 ORTHOFIX MEDICAL: MAJOR PRODUCT OFFERINGS

TABLE 65 STRYKER: MAJOR PRODUCT OFFERINGS

TABLE 66 ZIMMER BIOMET: MAJOR PRODUCT OFFERINGS

TABLE 67 ALTIS BIOLOGICS: MAJOR PRODUCT OFFERINGS

TABLE 68 BIO DYNAMIC TECHNOLOGIES: MAJOR PRODUCT OFFERINGS

TABLE 69 BTT HEALTH: MAJOR PRODUCT OFFERINGS

TABLE 70 CELLUMED: MAJOR PRODUCT OFFERINGS

TABLE 71 EASTERN DME: MAJOR PRODUCT OFFERINGS

TABLE 72 ELIZUR: MAJOR PRODUCT OFFERINGS

TABLE 73 EMCYTE: MAJOR PRODUCT OFFERINGS

TABLE 74 FINTEK BIO-ELECTRIC: MAJOR PRODUCT OFFERINGS

TABLE 75 IGEA: MAJOR PRODUCT OFFERINGS

TABLE 76 ITO: MAJOR PRODUCT OFFERINGS

TABLE 77 KINEX MEDICAL: MAJOR PRODUCT OFFERINGS

TABLE 78 OSSATEC BENELUX: MAJOR PRODUCT OFFERINGS

TABLE 79 PAIN REHAB PRODUCTS: MAJOR PRODUCT OFFERINGS

TABLE 80 ROYAL BIOLOGICS: MAJOR PRODUCT OFFERINGS

TABLE 81 SHENANDOAH BIOTECHNOLOGY: MAJOR PRODUCT OFFERINGS

TABLE 82 SMITH+NEPHEW: MAJOR PRODUCT OFFERINGS

TABLE 83 SPECIALIZED ORTHOPEDIC SOLUTIONS: MAJOR PRODUCT OFFERINGS

TABLE 84 STIMULATE HEALTH: MAJOR PRODUCT OFFERINGS

TABLE 85 TERUMO: MAJOR PRODUCT OFFERINGS

TABLE 86 GLOBAL BONE GROWTH PRODUCTS MARKET BY PRODUCT TYPE 2021–2027 ($ MILLION)

TABLE 87 GLOBAL BONE GROWTH PRODUCTS MARKET BY PRODUCT TYPE 2021–2027 (%)

TABLE 88 NORTH AMERICA BONE GROWTH PRODUCTS MARKET BY PRODUCT TYPE 2021–2027 ($ MILLION)

TABLE 89 NORTH AMERICA BONE GROWTH PRODUCTS MARKET BY PRODUCT TYPE 2021–2027 (%)

TABLE 90 EUROPE BONE GROWTH PRODUCTS MARKET BY PRODUCT TYPE 2021–2027 ($ MILLION)

TABLE 91 EUROPE BONE GROWTH PRODUCTS MARKET BY PRODUCT TYPE 2021–2027 (%)

TABLE 92 APAC BONE GROWTH PRODUCTS MARKET BY PRODUCT TYPE 2021–2027 ($ MILLION)

TABLE 93 APAC BONE GROWTH PRODUCTS MARKET BY PRODUCT TYPE 2021–2027 (%)

TABLE 94 LATIN AMERICA BONE GROWTH PRODUCTS MARKET BY PRODUCT TYPE 2021–2027 ($ MILLION)

TABLE 95 LATIN AMERICA BONE GROWTH PRODUCTS MARKET BY PRODUCT TYPE 2021–2027 (%)

TABLE 96 MIDDLE EAST & AFRICA BONE GROWTH PRODUCTS MARKET BY PRODUCT TYPE 2021–2027 ($ MILLION)

TABLE 97 MIDDLE EAST & AFRICA BONE GROWTH PRODUCTS MARKET BY PRODUCT TYPE 2021–2027 (%)

TABLE 98 GLOBAL BONE GROWTH PRODUCTS MARKET BY APPLICATION 2021–2027 ($ MILLION)

TABLE 99 GLOBAL BONE GROWTH PRODUCTS MARKET BY APPLICATION 2021–2027 (%)

TABLE 100 NORTH AMERICA BONE GROWTH PRODUCTS MARKET BY APPLICATION 2021–2027 ($ MILLION)

TABLE 101 NORTH AMERICA BONE GROWTH PRODUCTS MARKET BY APPLICATION 2021–2027 (%)

TABLE 102 EUROPE BONE GROWTH PRODUCTS MARKET BY APPLICATION 2021–2027 ($ MILLION)

TABLE 103 EUROPE BONE GROWTH PRODUCTS MARKET BY APPLICATION 2021–2027 (%)

TABLE 104 APAC BONE GROWTH PRODUCTS MARKET BY APPLICATION 2021–2027 ($ MILLION)

TABLE 105 APAC BONE GROWTH PRODUCTS MARKET BY APPLICATION 2021–2027 (%)

TABLE 106 LATIN AMERICA BONE GROWTH PRODUCTS MARKET BY APPLICATION 2021–2027 ($ MILLION)

TABLE 107 LATIN AMERICA BONE GROWTH PRODUCTS MARKET BY APPLICATION 2021–2027 (%)

TABLE 108 MIDDLE EAST & AFRICA BONE GROWTH PRODUCTS MARKET BY APPLICATION 2021–2027 ($ MILLION)

TABLE 109 MIDDLE EAST & AFRICA BONE GROWTH PRODUCTS MARKET BY APPLICATION 2021–2027 (%)

TABLE 110 GLOBAL BONE GROWTH PRODUCTS MARKET BY END-USER 2021–2027 ($ MILLION)

TABLE 111 GLOBAL BONE GROWTH PRODUCTS MARKET BY END-USER 2021–2027 (%)

TABLE 112 NORTH AMERICA BONE GROWTH PRODUCTS MARKET BY END-USER 2021–2027 ($ MILLION)

TABLE 113 NORTH AMERICA BONE GROWTH PRODUCTS MARKET BY END-USER 2021–2027 (%)

TABLE 114 EUROPE BONE GROWTH PRODUCTS MARKET BY END-USER 2021–2027 ($ MILLION)

TABLE 115 EUROPE BONE GROWTH PRODUCTS MARKET BY END-USER 2021–2027 (%)

TABLE 116 APAC BONE GROWTH PRODUCTS MARKET BY END-USER 2021–2027 ($ MILLION)

TABLE 117 APAC BONE GROWTH PRODUCTS MARKET BY END-USER 2021–2027 (%)

TABLE 118 LATIN AMERICA BONE GROWTH PRODUCTS MARKET BY END-USER 2021–2027 ($ MILLION)

TABLE 119 LATIN AMERICA BONE GROWTH PRODUCTS MARKET BY END-USER 2021–2027 (%)

TABLE 120 MIDDLE EAST & AFRICA BONE GROWTH PRODUCTS MARKET BY END-USER 2021–2027 ($ MILLION)

TABLE 121 MIDDLE EAST & AFRICA BONE GROWTH PRODUCTS MARKET BY END-USER 2021–2027 (%)

TABLE 122 GLOBAL BONE GROWTH PRODUCTS MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)

TABLE 123 GLOBAL BONE GROWTH PRODUCTS MARKET BY GEOGRAPHY 2021–2027 (%)

TABLE 124 BONE GROWTH STIMULATOR DEVICES MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)

TABLE 125 BONE GROWTH STIMULATOR DEVICES MARKET BY GEOGRAPHY 2021–2027 (%)

TABLE 126 BONE MORPHOGENETIC PROTEIN MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)

TABLE 127 BONE MORPHOGENETIC PROTEIN MARKET BY GEOGRAPHY 2021–2027 (%)

TABLE 128 PLATELET RICH PLASMA MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)

TABLE 129 PLATELET RICH PLASMA MARKET BY GEOGRAPHY 2021–2027 (%)

TABLE 130 SPINAL FUSION SURGERIES MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)

TABLE 131 SPINAL FUSION SURGERIES MARKET BY GEOGRAPHY 2021–2027 (%)

TABLE 132 ORAL MAXILLOFACIAL SURGERIES MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)

TABLE 133 ORAL MAXILLOFACIAL SURGERIES IN BONE GROWTH PRODUCTS MARKET BY GEOGRAPHY 2021–2027 (%)

TABLE 134 DELAYED UNION & NON-UNION BONE FRACTURES MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)

TABLE 135 DELAYED UNION & NON-UNION BONE FRACTURES MARKET BY GEOGRAPHY 2021–2027 (%)

TABLE 136 OTHER BONE GROWTH PRODUCTS MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)

TABLE 137 OTHER BONE GROWTH PRODUCTS MARKET BY GEOGRAPHY 2021–2027 (%)

TABLE 138 HOSPITALS & CLINICS BONE GROWTH PRODUCTS MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)

TABLE 139 HOSPITALS & CLINICS BONE GROWTH PRODUCTS MARKET BY GEOGRAPHY 2021–2027 (%)

TABLE 140 SPECIALTY ORTHOPEDIC & SPINE CENTER BONE GROWTH PRODUCTS MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)

TABLE 141 SPECIALTY ORTHOPEDIC & SPINE CENTER BONE GROWTH PRODUCTS MARKET BY GEOGRAPHY 2021–2027 (%)

TABLE 142 ASCS BONE GROWTH PRODUCTS MARKET BY GEOGRAPHY 2021–2027 ($ MILLION)

TABLE 143 ASCS BONE GROWTH PRODUCTS MARKET BY GEOGRAPHY 2021–2027 (%)

Select a license type that suits your business needs

single-user Single User Licence
$3750.00
  • Report accessible by one user only
  • Free 10% or 3 days of customization
  • Free post-sale service assistance
  • Continuous support through email
Best Value Tag
5-user 5 User Licence
$4250.00
  • Report accessible by 5 users within the organization
  • Free 15% or 4.5 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
corporate.png Corporate Licence
$5250.00
  • Free Datasheet worth $1500
  • Report accessible by the entire organization
  • Free 20% or 6 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Direct access to lead analysts
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
datasheet.png Datasheet Licence
$1500.00
  • Report accessible by 1 user only
  • Free 15% or 32 hours of customization
  • Free post-sale service assistance
  • Direct access to lead analysts

Our Clients

Licence Types What are these?

Our Clients Speak

erick

"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."

Erik Young
CEO, Co-founder
Audink Inc., DBA Audios
SPEAK WITH OUR ANALYST

Want to know more about the report or any specific requirement?

Click to Email +1-312-235-2040

Want to Customize the Report?

Click Here

Why Arizton?

  • 100% Customer Satisfaction
  • 24x7 availability – we are always there when you need us
  • 200+ Fortune 500 Companies trust Arizton's report
  • 80% of our reports are exclusive and first in the industry
  • 100% more data and analysis
  • 1000+ reports published till date